Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Manage cookies
Accept & continue
  • Sign In
  • Subscribe
Open drawer menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • Shock within Westminster at Johnson’s rapid deterioration
    • Bank of England to directly finance UK government’s extra spending
    • Eurozone’s two biggest economies sink into historic recessions
    • Britain banks on youth to lead way out of lockdown
    • Fed to provide extra $2.3tn in loans
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    • US Presidential Election
    Most Read
    • Coronavirus: US death toll passes 16,000 level
    • G20 ministers meet to endorse Opec-Russia deal to slash oil production
    • Opec seeks grand bargain to lift prices amid pandemic 
    • Fed to provide extra $2.3tn in loans
    • Wall St urges caution as bullish investors rush into recovery bets
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Opec seeks grand bargain to lift prices amid pandemic 
    • Aviva pension clients barred from cashing in property assets
    • UK tenants pay less than half owed in rent
    • US banks fret over fine print in small business rescue plan
    • Battle for Premier League survival moves off the pitch
  • Tech
  • Markets
    Sections
    • Markets Home
    • fastFT
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    Most Read
    • Bank of England to directly finance UK government’s extra spending
    • ‘50 cent’ fund makes $2.6bn from buying protection against collapse
    • Fed to provide extra $2.3tn in loans
    • Wall St urges caution as bullish investors rush into recovery bets
    • Federal Reserve action boosts equity and credit markets
  • Graphics
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Instant Insight
    • Lex
    • Alphaville
    • Obituaries
    • Letters
    Most Read
    • The pandemic will forever transform how we live
    • The danger in the global coronavirus recovery will be inertia
    • Painful lessons from the Luckin Coffee scandal
    • Markets are only starting to come to terms with the new normal
    • Investors should ask who will buy all of this new US government debt
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Coronavirus Diaries: a headmaster and a bank exec on their contrasting lives in lockdown
    • What are good — and less expensive — alternatives to an MBA?
    • Zoom in on your lockdown meeting techniques | Free to read
    • How to make planning by committee a success
    • Coronavirus Diaries: Martin Wolf on the pain of family separation | Free to read
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Arundhati Roy: ‘The pandemic is a portal’ | Free to read 
    • The pandemic will forever transform how we live
    • UK property market moves into cold storage
    • How much TV should your children be watching right now?
    • Vaccines and antibiotics made the west complacent. This must change
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Graphics
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

Coronavirus business update Get 30 days complimentary access to our Coronavirus Business Update newsletter 30 days complimentary

Promotion for Financial Times' Coronavirus Business Update newsletter explaining the Coronavirus' impact on the global financial markets
Get the newsletter now

Hannah Kuchler

US pharma and biotech correspondent
Hannah Kuchler reports on pharma, biotech and healthcare. After covering Silicon Valley for over five years, she's now focusing on how technology is transforming our health.
Email Hannah Kuchler @hannahkuchler (link opens in a new browser window)
Email Hannah Kuchler @hannahkuchler (link opens in a new browser window)

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 10 April, 2020
    Lunch with the FT
    Anne Wojcicki: ‘This is the way the world is going’

    As chief executive of 23andMe, she holds the key to a vast genetic database. What will she do with it?

  • Tuesday, 7 April, 2020
    Social and environmental impact investment
    Wellcome seeks $8bn from business to fight coronavirus

    Research group launches ‘Covid-zero’ to fund hunt for vaccines, treatments and testing

  • Tuesday, 7 April, 2020
    InterviewHow to Lead
    Lessons from a CEO on New York’s coronavirus frontline

    The New York-Presbyterian boss has moved swiftly to respond to the pandemic

  • Monday, 6 April, 2020
    Coronavirus
    US report reveals hospitals’ struggle with shortages    

    Administrators plead for more government co-ordination on supplies, staffing and communication

  • Monday, 6 April, 2020
    Coronavirus
    GSK buys $250m biotech stake in hunt for Covid-19 treatment

    Investment in Vir Biotechnology accelerates race for an antibody treatment for coronavirus

  • Saturday, 4 April, 2020
    Coronavirus
    US coronavirus hotspots desperately seek trained medical staff

    Appeals made to bring more doctors, nurses and healthcare workers into hardest-hit regions

  • Friday, 3 April, 2020
    AnalysisPharmaceuticals sector
    Johnson & Johnson chief looks to the greater good

    Decision to make any coronavirus vaccine available on a non-profit basis chimes with group’s corporate values

  • Wednesday, 1 April, 2020
    Pharmaceuticals sector
    US drugs regulator calls for halt to Zantac sales

    Heartburn medication made by Sanofi of France has been linked to cancer-causing impurity

  • Wednesday, 1 April, 2020
    AnalysisTechnology
    The ventilator challenge will test ingenuity to the limit

    Manufacturers face technical, logistical and regulatory hurdles as they step outside their comfort zone

  • Promoted Content
  • Wednesday, 1 April, 2020
    Pharmaceuticals sector
    US hospitals face severe ventilator drugs shortage

    Coronavirus outbreak has caused a 51% increase in demand for sedatives and anaesthetics in March

  • Tuesday, 31 March, 2020
    Coronavirus
    US companies launch rapid antibody test

    Point-of-care examination set to detect evidence of virus in as little as 15 minutes

  • Monday, 30 March, 2020
    Coronavirus
    Gates Foundation and Wellcome Trust to fund Covid-19 drug trials 

    Accelerator fund will test whether existing drugs such as chloroquine can treat coronavirus

  • Monday, 30 March, 2020
    Coronavirus
    J&J and Abbott flag potential vaccine and rapid test

    US healthcare groups bring hope in race to fight coronavirus pandemic

  • Monday, 30 March, 2020
    Special ReportBoldness in Business
    Technology: Healthy.io marries machine learning and medicine

    The Israeli start-up’s smartphone-based urine tests could bring huge savings for health services

  • Friday, 27 March, 2020
    AnalysisThe Big Read
    Donald Trump’s chaotic coronavirus crisis

    Fixated on re-election, the president has struggled to respond as the pandemic takes hold in the US

  • Thursday, 26 March, 2020
    Coronavirus: free to read
    The global hunt for a coronavirus drug

    With a vaccine up to 18 months away, drug companies are testing existing virus treatments 

  • Wednesday, 25 March, 2020
    Coronavirus
    Gilead asks to rescind special status for potential virus drug

    Drugmaker had come under fire for ‘orphan’ ranking that conferred pricing and tax benefits 

  • Wednesday, 25 March, 2020
    Drugs research
    Global rush for coronavirus drug sees India stop exports

    Supplies of chloroquine hoarded despite lack of concrete evidence about its effectiveness

  • Monday, 23 March, 2020
    Coronavirus
    AbbVie drops patent rights for Kaletra antiviral treatment

    Combination drug is being studied in several trials as a coronavirus treatment

  • Saturday, 21 March, 2020
    Coronavirus
    White House adviser says US stimulus could top $2tn

    Measures to stem fallout from coronavirus could include cash handouts and loans to business

  • Saturday, 21 March, 2020
    Coronavirus
    US hospitals panic-buy drugs ahead of coronavirus influx

    Shortages of antimalarials and inhalers feared as purchases spike

  • Saturday, 21 March, 2020
    FT CollectionsData rich: the numbers behind corporate news
    Race to find treatment using re-engineered medicines

    Trials start using drugs designed for other conditions to help combat Covid-19

  • Friday, 20 March, 2020
    AnalysisCoronavirus
    Biotech start-ups race to create quicker coronavirus tests

    Pioneers hope methods based on Crispr gene-editing technique will allow faster, more accurate diagnosis

  • Thursday, 19 March, 2020
    Pharmaceuticals sector
    US drugmaker doubled price on potential coronavirus treatment

    Therapy touted by Trump made more expensive in January as China outbreak spread

  • Thursday, 19 March, 2020
    Coronavirus
    FDA contradicts Trump on potential coronavirus drug

    Regulator undercuts president’s claim that anti-malarial is approved to treat Covid-19

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubMBA Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2020. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
    • US Presidential Election
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • fastFT
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
  • Graphics
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Instant Insight
    • Lex
    • Alphaville
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • Tech Scroll Asia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In